Latest Tofacitinib Stories
-33% rate of DAS28-CRP remission or low disease activity reported in Phase 2a cohort- MONROVIA, Calif., Jan. 29, 2015 /PRNewswire/ -- Xencor, Inc.
Independent, 3rd party scientists review psoriasis treatments and the benefits of small molecule drugs including CF101; PETACH TIKVA, Israel, Sept.
Doctors at Yale University administered treatment for a non-curable disease (alopecia universalis) in a 25-year-old man that left him without any hair. After the treatment, the man grew a full head of hair.
New oral XELJANZ( TM), now available in Canada KIRKLAND, QC, June 4, 2014 /CNW/ - Catherine Hofstetter was diagnosed with rheumatoid arthritis 22 years ago and it changed her
ReportsnReports.com offers Therapeutic Class Overview: Psoriasis – Plaque Psoriasis & Psoriatic Arthritis: Novel Oral drugs and Biologics to Change Future Treatment Paradigm market research
New research shows mortality rates are two times higher in postmenopausal women with rheumatoid arthritis (RA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies.
Reportbuyer.com just published a new market research report:
- Emitting flashes of light; glittering.